I. Willner et al.
could be useful sensing devices to monitor TR activity for
the rapid detection of melanoma cancer cells. In the present
studies we used two different principles to control the gate
potential. The first approach involved the alteration of the
change associated with the gate by linking the product of
the biocatalytic transformation with the boronic acid ligand
that was attached to the ISFETdevice. Th e second method
to control the gate potential included the generation of a
redox-active product (dopaquinone) that gave an electro-
chemical potential on the surface of the gate. All previous
methods for the analysis of TR activity involved metallic
[
9]
[11]
nanoparticles, semiconductor QDs,
or functionalized
Figure 3. A) Gate-to-source potential changes upon analyzing different
concentrations of TR by using the same ISFET device functionalized
with 1. Curve a) shows the potential changes as a result of oxidation of 1
by different concentrations of TR that yield the dopaquinone. Curve b)
shows the changes in the gate-to-source potential after treatment of the
dopaquinone-modified ISFETwith ascorbic acid (1 m m) in phosphate
buffer (0.01m, pH 6.3). The results indicate the regeneration of the base
potential of the ISFETdevice prior to analysis of any of the TR concen-
trations. B) Gate-to-source potential changes upon analyzing different
concentrations of TR by using the 3-modified ISFET. Measurements
were performed in phosphate buffer (0.01m, pH 6.3).
[10]
redox molecules, as labels for the optical or electrochemi-
cal detection of TR activity. The present study demonstrates
a label-free procedure for analyzing TR activities with com-
parable sensitivities to previous methods.
Experimental Section
Materials: Compounds 1, 2, 3, TR, 3-aminopropyltriethoxysilane, 1-[3-
(
dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC), as-
corbic acid, citric acid, and glutaric dialdehyde were purchased from
Sigma or Aldrich and used as supplied. Ultrapure water obtained from
Barnstead NANOpure DIamond was used in all experiments.
b), which implies that all of the enzyme-generated dopaqui-
none was reduced to form the 1-functionalized surfaces. In
fact, the TR-stimulated oxidation of 3 to dopaquinone and
the back reduction of dopaquinone to 1 are fully reversible
Preparation of the modified ISFET devices: The primary modification of
the Al O gate of an ISFETdevice was achieved by treating the ISFET
2 3
with a solution of 3-aminopropyltriethoxysilane (0.2 mL, 10% (v/v) in tol-
uene) at room temperature for 12 h.
(
Figure 3A). These results confirm that the oxidation of 3
Preparation of the 2-functionalized ISFET: The silylated chips were thor-
oughly rinsed with toluene followed by a HEPES buffer solution (10 mm,
pH 6.3), and were subsequently dried in air at room temperature for
30 min. Compound 2 was then covalently linked to the aminosiloxane-
functionalized gate interface by treating the gate with HEPES buffer
on the surface lead to the formation of dopaquinone, which
is reduced by ascorbate to form the 1-functionalized surfa-
ces. Furthermore, the results imply that the 1-functionalized
ISFETdevices may be used as biosensors to follow TR ac-
tivity, and that the reduction of the dopaquinone product
may be used as a means of regenerating the interface.
(
0.2 mL) solution that contained 2 (1 mm) and EDC (10 mm) for 2 h. The
resulting modified ISFETdevices were thoroughly rinsed with the
HEPES buffer solution and dried in air for 30 min.
The development of the 3-modified ISFETdevice as a
bioelectronic device that transduces the biocatalyzed forma-
tion of 1 on the surface of the gate enabled us to construct a
new biosensor configuration for analyzing TR activity. Fig-
ure 3B shows the changes in the potential of the gate modi-
fied with 3 upon the analysis of different concentrations of
TR. In these experiments, the 3-modified ISFETs were
treated with different concentrations of TR (for a fixed time
interval of 20 min), and the resulting dopaquinone-function-
alized gates were reduced with ascorbate (Scheme 3, route
a). As the concentration of TR was increased, the change in
Preparation of the 1- or 3-functionalized ISFETs: Compound 1 was cova-
lently linked to the aminosiloxane-functionalized gate interface by treat-
ing of the gate with glutaric dialdehyde (0.2 mL, 10% (v/v) solution in
water) at room temperature for 20 min. The chips were rinsed with water
and then with a HEPES buffer solution (10 mm, pH 6.3) and then treated
with 1 (0.2 mL, 1 mm in HEPES buffer solution) for 20 min. The 3-modi-
fied gates were prepared by the same procedure as described for 1.
Potentiometric ISFET measurements: ISFETdevices (IM T, Neuchâtel,
Switzerland) with Al O gates (20 mm700 mm) were used in all experi-
2
3
ments. A conventional Ag/AgCl electrode was used as a reference elec-
trode. The 2-functionalized gate was immersed in a working cell com-
posed of phosphate buffer solution (0.8 mL, 0.01m, pH 8.8), which con-
tained 1 (1 mm). To follow the time-dependent potential changes on the
surface of the gate, the measurement of the gate-to-source potentials
were monitored for a time interval of 30 min. To extract the calibration
curve for 1, the 2-functionalized ISFETs were exposed to various concen-
trations of 1 for 20 min, and the resulting devices were immersed in a
working cell composed of phosphate buffer solution (0.8 mL, 0.01m,
pH 8.8).
the gate-to-source potential (DV ) was enhanced, which is
gs
consistent with the fact that the coverage of 1 on the surface
of the gate was increased.
Conclusion
To follow the activity of TR, a solution of3 (1 mm) was treated with vari-
able concentrations of TR in phosphate buffer (200 mL, 10 mm, pH 6.3)
for a fixed time interval of 20 min. Subsequently, the enzyme was ther-
mally deactivated by heating the sample at 808 for 2 min. The resulting
mixture consisted of 1 and dopaquinone. The mixture was treated with
citric acid (1 mm) for 5 min to reduce to 1 any dopaquinone that had
been generated. The 2-functionalized ISFETdevices were then treated
with the mixtures (0.2 mL) for a time interval of 20 min. The resulting de-
In conclusion, the present study has demonstrated the novel
use of ISFETdevices for the analysis of 1 or for the assay of
TR. The 2-functionalized ISFETcould provide a useful min-
iaturized implantable electronic system for monitoring the
neurotransmitter 1. Similarly, 3- or 1-functionalized ISFETs
7292
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2007, 13, 7288 – 7293